Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 112 citing Weigner: Risk for clinical thromboembolism associated with conversion to sinus rhythm in.... (0.14 sec) 

[PDF] Antithrombotic Therapy in


A Laupacis, G Albers - Chest, 1998 - Am Coll Chest Phys
DOI 10.1378/chest.114.5_Supplement.579S 1998;114;579S-589S Chest ... Alan K. Jacobson
and Daniel E. Singer Andreas Laupacis, Gregory Albers, James Dalen, Marvin I. Dunn, ...
S.citation http://www.chestjournal.org/content/114/5_Supplement/579 and services can ...
Cited by 749 - Related articles - BL Direct - All 10 versions

Antithrombotic therapy in atrial fibrillation

- chestpubs.org
DE Singer, AS Go - Clinics in geriatric medicine, 2001 - Elsevier
Based solely on observational data, long-term anticoagulation has been a favored therapy to
prevent stroke in rheumatic AF. 47 It was unclear whether anticoagulants would work in nonrheumatic
AF or whether they would be sufficiently safe in the typical elderly patient with this ...
Cited by 568 - Related articles - BL Direct - All 17 versions

Antithrombotic therapy in atrial fibrillation


GW Albers, JE Dalen, A Laupacis, WJ Manning, P … - Chest, 2001 - chestjournal.chestpubs.org
In the SPAF-3 high-risk study, 8 AF patients who had at least one of four thromboembolic risk
factors (congestive heart failure or left ventricular [LV] fractional shortening ≤ 25%, history of
a previous thromboembolism, systolic BP > 160 mm Hg at study entry, or female gender > ...
Cited by 525 - Related articles - BL Direct - All 16 versions

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in …


GV Naccarelli, DL Wolbrette, M Khan, L Bhatta, J … - The American journal of …, 2003 - Elsevier
In managing atrial fibrillation (AF), the main therapeutic strategies include rate control, termination
of the arrhythmia, and the prevention of recurrences and thromboembolic events. Safety and
efficacy considerations are important in optimizing the choice of an antiarrhythmic drug for ...
Cited by 111 - Related articles - All 5 versions

Cost-effective management of acute atrial fibrillation: role of rate control, …


GV Naccarelli, JT Dell'Orfano, DL Wolbrette, HM … - The American journal of …, 2000 - Elsevier
Management strategies for the acute treatment of atrial fibrillation (AF) include: (1) the use of
intravenous drugs for rate control, (2) drug termination, or (3) direct current (DC)
cardioversion. Delays in cardioversion can promote atrial remodeling and add ...
Cited by 75 - Related articles - BL Direct - All 5 versions

Controversies in atrial fibrillation

- tuftsanesthesia.org [PDF] 
S Nattel, LH Opie - The Lancet, 2006 - Elsevier
Atrial fibrillation is the most common sustained cardiac arrhythmia, and contributes greatly to
cardiovascular morbidity and mortality. Many aspects of the management of atrial fibrillation remain
controversial. We address nine specific controversies in atrial fibrillation management, ...
Cited by 76 - Related articles - All 12 versions

Embolic complications of direct current cardioversion of atrial arrhythmias: …

- onlinejacc.org
MM Gallagher, BJ Hennessy, N Edvardsson, CM … - Journal of the American …, 2002 - Elsevier
Direct current cardioversion of atrial fibrillation (AF) carries a risk of thromboembolism, which
is reduced, but not eliminated, by anticoagulation. The risk of embolism after conversion of atrial
flutter is believed to be lower. No series to date has included enough patients receiving ...
Cited by 59 - Related articles - BL Direct - All 14 versions

Cardioversion of paroxysmal atrial fibrillation in the emergency department


JA Michael, IG Stiell, S Agarwal, DP Mandavia - Annals of emergency medicine, 1999 - Elsevier
Most patients who present to the ED with new-onset or acute atrial fibrillation are admitted to
hospital. This is done to exclude serious underlying cardiac pathologic condition as a cause
for the arrhythmia and to monitor for significant complications. 3 Anti-arrhythmic therapy ...
Cited by 52 - Related articles - BL Direct - All 8 versions

Atrial fibrillation: epidemiology, mechanisms, and management


J Sra, A Dhala, Z Blanck, S Deshpande, R Cooley, … - Current problems in …, 2000 - Elsevier
The incidence of AF, the most common sustained arrhythmia in clinical practice, increases with
age, and coronary artery disease, hypertension, and valvular heart disease are common underlying
substrates. Occasionally, however, AF may occur without any underlying heart disease. ...
Cited by 31 - Related articles - BL Direct - All 2 versions

Use of oral anticoagulants in older patients

- adisonline.com [PDF] 
JL Sebastian, DD Tresch - Drugs &# 38; Aging, 2000 - ingentaconnect.com
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 410 1. Indications For Long
Term Anticoagulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 411 1.1 Nonvalvular Atrial Fibrillation
(NVAF) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 411 1.1.1 Risk Factors for Stroke in Patients ...
Cited by 33 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 

Go to Google Home - About Google - About Google Scholar

©2009 Google